{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:25:30Z","timestamp":1793467530404,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Obes Rep"],"DOI":"10.1007\/s13679-026-00760-1","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:32:56Z","timestamp":1789108376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Obesity-related Metabolic Dysfunction and Triple-negative Breast Cancer: Epidemiologic Signals, Mechanistic Pathways, and Opportunities for Prevention"],"prefix":"10.1007","volume":"15","author":[{"given":"Naser","family":"Elkum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelilah","family":"Aboussekhra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"3","key":"760_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"Ca-Cancer J Clin"},{"key":"760_CR2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.clnu.2025.04.002","volume":"48","author":"G Figlioli","year":"2025","unstructured":"Figlioli G, Piovani D, Tsantes AG, Pugliese N, Nikolopoulos GK, Hassan C, et al. Burden of cancer attributable to high body mass index: A systematic analysis of the Global Burden of Disease Study 2021. Clin Nutr. 2025;48:144\u201352. https:\/\/doi.org\/10.1016\/j.clnu.2025.04.002.","journal-title":"Clin Nutr"},{"issue":"2","key":"760_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1634\/theoncologist.2012-0397","volume":"18","author":"A Prat","year":"2013","unstructured":"Prat A, Adamo B, Cheang MC, Anders CK, Carey LA, Perou CM. Molecular characterization of basal-like and non-basal-like triple-negative breast cancer. Oncologist. 2013;18(2):123\u201333. https:\/\/doi.org\/10.1634\/theoncologist.2012-0397.","journal-title":"Oncologist"},{"issue":"7","key":"760_CR4","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750\u201367. https:\/\/doi.org\/10.1172\/JCI45014.","journal-title":"J Clin Invest"},{"issue":"21","key":"760_CR5","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492\u2013502. https:\/\/doi.org\/10.1001\/jama.295.21.2492.","journal-title":"JAMA"},{"issue":"3","key":"760_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10549-015-3353-z","volume":"150","author":"EV Bandera","year":"2015","unstructured":"Bandera EV, Chandran U, Hong CC, Troester MA, Bethea TN, Adams-Campbell LL, et al. Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium. Breast Cancer Res Treat. 2015;150(3):655\u201366. https:\/\/doi.org\/10.1007\/s10549-015-3353-z.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"760_CR7","doi-asserted-by":"publisher","first-page":"e2421846","DOI":"10.1001\/jamanetworkopen.2024.21846","volume":"7","author":"SK Sudan","year":"2024","unstructured":"Sudan SK, Sharma A, Vikramdeo KS, Davis W, Deshmukh SK, Poosarla T, et al. Obesity and Early-Onset Breast Cancer and Specific Molecular Subtype Diagnosis in Black and White Women: NIMHD Social Epigenomics Program. JAMA Netw Open. 2024;7(7):e2421846. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.21846.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"760_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1634\/theoncologist.2012-0373","volume":"18","author":"N Justo","year":"2013","unstructured":"Justo N, Wilking N, Jonsson B, Luciani S, Cazap E. A Review of Breast Cancer Care and Outcomes in Latin America. Oncologist. 2013;18(3):248\u201356. https:\/\/doi.org\/10.1634\/theoncologist.2012-0373.","journal-title":"Oncologist"},{"issue":"4","key":"760_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/ajco.12661","volume":"13","author":"S Malvia","year":"2017","unstructured":"Malvia S, Bagadi SA, Dubey US, Saxena S. Epidemiology of breast cancer in Indian women. Asia-Pac J Clin Onco. 2017;13(4):289\u201395. https:\/\/doi.org\/10.1111\/ajco.12661.","journal-title":"Asia-Pac J Clin Onco"},{"issue":"12","key":"760_CR10","doi-asserted-by":"publisher","first-page":"E923","DOI":"10.1016\/S2214-109x(16)30259-5","volume":"4","author":"E Jedy-Agba","year":"2016","unstructured":"Jedy-Agba E, McCormack V, Adebamowo C, Dos-Santos-Silva I. Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2016;4(12):E923\u201335. https:\/\/doi.org\/10.1016\/S2214-109x(16)30259-5.","journal-title":"Lancet Glob Health"},{"key":"760_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejca.2016.07.022","volume":"66","author":"R Nagrani","year":"2016","unstructured":"Nagrani R, Mhatre S, Rajaraman P, Soerjomataram I, Boffetta P, Gupta S, et al. Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian Ethnicity. Eur J Cancer. 2016;66:153\u201361. https:\/\/doi.org\/10.1016\/j.ejca.2016.07.022.","journal-title":"Eur J Cancer"},{"issue":"4","key":"760_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.14740\/wjon1303","volume":"11","author":"AA Adeniji","year":"2020","unstructured":"Adeniji AA, Dawodu OO, Habeebu MY, Oyekan AO, Bashir MA, Martin MG, et al. Distribution of Breast Cancer Subtypes Among Nigerian Women and Correlation to the Risk Factors and Clinicopathological Characteristics. World J Oncol. 2020;11(4):165\u201372. https:\/\/doi.org\/10.14740\/wjon1303.","journal-title":"World J Oncol"},{"issue":"27","key":"760_CR13","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1200\/Jco.2008.19.6873","volume":"27","author":"DZ Huo","year":"2009","unstructured":"Huo DZ, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, et al. Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer. J Clin Oncol. 2009;27(27):4515\u201321. https:\/\/doi.org\/10.1200\/Jco.2008.19.6873.","journal-title":"J Clin Oncol"},{"issue":"3","key":"760_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10555-022-10043-5","volume":"41","author":"EN Devericks","year":"2022","unstructured":"Devericks EN, Carson MS, McCullough LE, Coleman MF, Hursting SD. The obesity-breast cancer link: a multidisciplinary perspective. Cancer Metast Rev. 2022;41(3):607\u201325. https:\/\/doi.org\/10.1007\/s10555-022-10043-5.","journal-title":"Cancer Metast Rev"},{"issue":"10431","key":"760_CR15","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NCDRF Collaboration","year":"2024","unstructured":"Collaboration NCDRF. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(23)02750-2.","journal-title":"Lancet"},{"issue":"1","key":"760_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10549-012-2339-3","volume":"137","author":"M Pierobon","year":"2013","unstructured":"Pierobon M, Frankenfeld CL. Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137(1):307\u201314. https:\/\/doi.org\/10.1007\/s10549-012-2339-3.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"760_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/jnci\/djq526","volume":"103","author":"XR Yang","year":"2011","unstructured":"Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011;103(3):250\u201363. https:\/\/doi.org\/10.1093\/jnci\/djq526.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"760_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13058-025-02189-1","volume":"28","author":"N Elkum","year":"2026","unstructured":"Elkum N, Al-Zahrani AS, Alraouji NN, Al-Tweigeri T, Aboussekhra A. Obesity is a major modifiable factor associated with ER-negative breast cancer: epidemiological and mechanistic evidence from a high-risk cohort. Breast Cancer Res. 2026;28(1):29. https:\/\/doi.org\/10.1186\/s13058-025-02189-1.","journal-title":"Breast Cancer Res"},{"issue":"17","key":"760_CR19","doi-asserted-by":"publisher","first-page":"e00101","DOI":"10.1128\/MCB.00101-17","volume":"37","author":"HH Al-Khalaf","year":"2017","unstructured":"Al-Khalaf HH, Amir M, Al-Mohanna F, Tulbah A, Al-Sayed A, Aboussekhra A. Obesity and p16(INK4A) Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity. Mol Cell Biol. 2017;37(17):e00101\u201317. https:\/\/doi.org\/10.1128\/MCB.00101-17.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"760_CR20","doi-asserted-by":"publisher","first-page":"e00332","DOI":"10.1128\/MCB.00332-18","volume":"39","author":"HH Al-Khalaf","year":"2019","unstructured":"Al-Khalaf HH, Al-Harbi B, Al-Sayed A, Arafah M, Tulbah A, Jarman A, et al. Interleukin-8 Activates Breast Cancer-Associated Adipocytes and Promotes Their Angiogenesis- and Tumorigenesis-Promoting Effects. Mol Cell Biol. 2019;39(2):e00332\u201318. https:\/\/doi.org\/10.1128\/MCB.00332-18.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"760_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1158\/1940-6207.Capr-16-0314","volume":"10","author":"NM Iyengar","year":"2017","unstructured":"Iyengar NM, Brown KA, Zhou XK, Gucalp A, Subbaramaiah K, Giri DD, et al. Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index. Cancer Prev Res. 2017;10(4):235\u201343. https:\/\/doi.org\/10.1158\/1940-6207.Capr-16-0314.","journal-title":"Cancer Prev Res"},{"issue":"7","key":"760_CR22","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1158\/1940-6207.CAPR-11-0110","volume":"4","author":"PG Morris","year":"2011","unstructured":"Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK, et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila). 2011;4(7):1021\u20139. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-11-0110.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"760_CR23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392\u2013401. https:\/\/doi.org\/10.1038\/nrc1877.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"760_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell. 2005;121(3):335\u201348. https:\/\/doi.org\/10.1016\/j.cell.2005.02.034.","journal-title":"Cell"},{"issue":"6","key":"760_CR25","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/ijc.32504","volume":"146","author":"SG Dashti","year":"2020","unstructured":"Dashti SG, Simpson JA, Karahalios A, Viallon V, Moreno-Betancur M, Gurrin LC, et al. Adiposity and estrogen receptor-positive, postmenopausal breast cancer risk: Quantification of the mediating effects of fasting insulin and free estradiol. Int J Cancer. 2020;146(6):1541\u201352. https:\/\/doi.org\/10.1002\/ijc.32504.","journal-title":"Int J Cancer"},{"key":"760_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jsbmb.2019.03.002","volume":"189","author":"P Bhardwaj","year":"2019","unstructured":"Bhardwaj P, Au CC, Benito-Martin A, Ladumor H, Oshchepkova S, Moges R, et al. Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression. J Steroid Biochem Mol Biol. 2019;189:161\u201370. https:\/\/doi.org\/10.1016\/j.jsbmb.2019.03.002.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"760_CR27","doi-asserted-by":"publisher","first-page":"2611203","DOI":"10.1080\/07853890.2025.2611203","volume":"58","author":"H Zhang","year":"2026","unstructured":"Zhang H, Wang Y, Ning B, Wang Y, Sun T, Xu J. The gut microbiota-obesity axis in the pathogenesis and prognosis of breast cancer. Ann Med. 2026;58(1):2611203. https:\/\/doi.org\/10.1080\/07853890.2025.2611203.","journal-title":"Ann Med"},{"issue":"1","key":"760_CR28","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1186\/s12885-024-12721-9","volume":"24","author":"W Lin","year":"2024","unstructured":"Lin W, Gu C, Chen Z, Xue S, Wu H, Zeng L. Exploring the relationship between gut microbiota and breast cancer risk in European and East Asian populations using Mendelian randomization. BMC Cancer. 2024;24(1):970. https:\/\/doi.org\/10.1186\/s12885-024-12721-9.","journal-title":"BMC Cancer"},{"issue":"3","key":"760_CR29","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1007\/s11030-025-11351-y","volume":"30","author":"T Yuan","year":"2026","unstructured":"Yuan T, Xing J, Liu P. Decoding the gut microbiota metabolite-matrix metalloproteinase-3 axis in breast cancer: a multi-omics and network pharmacology study. Mol Divers. 2026;30(3):4059\u201371. https:\/\/doi.org\/10.1007\/s11030-025-11351-y.","journal-title":"Mol Divers"},{"issue":"1","key":"760_CR30","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1007\/s12672-025-03379-1","volume":"16","author":"J Yue","year":"2025","unstructured":"Yue J, Gu L, Chen S, Wen F, Huang G. Gut microbiota and breast cancer risk: a Mendelian randomization study stratified by ER status. Discov Oncol. 2025;16(1):1526. https:\/\/doi.org\/10.1007\/s12672-025-03379-1.","journal-title":"Discov Oncol"},{"issue":"3","key":"760_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10549-023-07139-z","volume":"203","author":"XC Li","year":"2024","unstructured":"Li XC, Li JP, Hu QR, Zhang X, Chen F. Association of physical weight statuses defined by body mass index (BMI) with molecular subtypes of premenopausal breast cancer: a systematic review and meta-analysis. Breast Cancer Res Tr. 2024;203(3):429\u201347. https:\/\/doi.org\/10.1007\/s10549-023-07139-z.","journal-title":"Breast Cancer Res Tr"},{"key":"760_CR32","doi-asserted-by":"publisher","first-page":"104710","DOI":"10.1016\/j.breast.2026.104710","volume":"86","author":"C Dauccia","year":"2026","unstructured":"Dauccia C, Bruzzone M, Arecco L, Blondeaux E, Sirico M, Gerosa R, et al. Association between body mass index and risk of breast cancer according to breast cancer subtypes: A systematic review and meta-analysis. Breast. 2026;86:104710. https:\/\/doi.org\/10.1016\/j.breast.2026.104710.","journal-title":"Breast"},{"issue":"10","key":"760_CR33","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1158\/1055-9965.EPI-20-0358","volume":"29","author":"MCS Bissell","year":"2020","unstructured":"Bissell MCS, Kerlikowske K, Sprague BL, Tice JA, Gard CC, Tossas KY, et al. Breast Cancer Population Attributable Risk Proportions Associated with Body Mass Index and Breast Density by Race\/Ethnicity and Menopausal Status. Cancer Epidemiol Biomarkers Prev. 2020;29(10):2048\u201356. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-0358.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"760_CR34","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1111\/j.1349-7006.2011.01996.x","volume":"102","author":"M Iwasaki","year":"2011","unstructured":"Iwasaki M, Tsugane S. Risk factors for breast cancer: epidemiological evidence from Japanese studies. Cancer Sci. 2011;102(9):1607\u201314. https:\/\/doi.org\/10.1111\/j.1349-7006.2011.01996.x.","journal-title":"Cancer Sci"},{"issue":"9","key":"760_CR35","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1038\/s41416-024-02857-7","volume":"131","author":"Y Mahamat-Saleh","year":"2024","unstructured":"Mahamat-Saleh Y, Aune D, Freisling H, Hardikar S, Jaafar R, Rinaldi S, et al. Association of metabolic obesity phenotypes with risk of overall and site-specific cancers: a systematic review and meta-analysis of cohort studies. Brit J Cancer. 2024;131(9):1480\u201395. https:\/\/doi.org\/10.1038\/s41416-024-02857-7.","journal-title":"Brit J Cancer"},{"issue":"1","key":"760_CR36","doi-asserted-by":"publisher","first-page":"e70244","DOI":"10.1002\/cncr.70244","volume":"132","author":"HL Choi","year":"2026","unstructured":"Choi HL, Kim B, Park YM, Yoo JE, Kim S, Jeong SM, et al. Metabolic obesity phenotypes and breast cancer risk before and after menopause: A nationwide cohort study in South Korea. Cancer-Am Cancer Soc. 2026;132(1):e70244. https:\/\/doi.org\/10.1002\/cncr.70244.","journal-title":"Cancer-Am Cancer Soc"},{"key":"760_CR37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/1471-2407-7-222","volume":"7","author":"N Elkum","year":"2007","unstructured":"Elkum N, Dermime S, Ajarim D, Al-Zahrani A, Alsayed A, Tulbah A, et al. Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC Cancer. 2007;7:222. https:\/\/doi.org\/10.1186\/1471-2407-7-222.","journal-title":"BMC Cancer"},{"issue":"22","key":"760_CR38","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.3390\/cancers15225398","volume":"15","author":"HO Al-Shamsi","year":"2023","unstructured":"Al-Shamsi HO, Abdelwahed N, Abyad A, Abu-Gheida I, Afrit M, Abu ElFuol T, et al. Breast Cancer in the Arabian Gulf Countries. Cancers (Basel). 2023;15(22):5398. https:\/\/doi.org\/10.3390\/cancers15225398.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"760_CR39","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/JCI21625","volume":"114","author":"S Furukawa","year":"2004","unstructured":"Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752\u201361. https:\/\/doi.org\/10.1172\/JCI21625.","journal-title":"J Clin Invest"},{"issue":"684","key":"760_CR40","doi-asserted-by":"publisher","first-page":"eade1857","DOI":"10.1126\/scitranslmed.ade1857","volume":"15","author":"P Bhardwaj","year":"2023","unstructured":"Bhardwaj P, Iyengar NM, Zahid H, Carter KM, Byun DJ, Choi MH, et al. Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2. Sci Transl Med. 2023;15(684):eade1857. https:\/\/doi.org\/10.1126\/scitranslmed.ade1857.","journal-title":"Sci Transl Med"},{"issue":"7","key":"760_CR41","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1470-2045(09)70159-7","volume":"10","author":"L Sjostrom","year":"2009","unstructured":"Sjostrom L, Gummesson A, Sjostrom CD, Narbro K, Peltonen M, Wedel H, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10(7):653\u201362. https:\/\/doi.org\/10.1016\/S1470-2045(09)70159-7.","journal-title":"Lancet Oncol"},{"issue":"2","key":"760_CR42","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ygyno.2017.02.036","volume":"145","author":"\u00c5 Anveden","year":"2017","unstructured":"Anveden \u00c5, Taube M, Peltonen M, Jacobson P, Andersson-Assarsson JC, Sj\u00f6holm K, et al. Long-term incidence of female-specific cancer after bariatric surgery or usual care in the Swedish Obese Subjects Study. Gynecol Oncol. 2017;145(2):224\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2017.02.036.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"760_CR43","doi-asserted-by":"publisher","first-page":"e1002105","DOI":"10.1371\/journal.pmed.1002105","volume":"13","author":"Y Guo","year":"2016","unstructured":"Guo Y, Warren Andersen S, Shu XO, Michailidou K, Bolla MK, Wang Q, et al. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. PLoS Med. 2016;13(8):e1002105. https:\/\/doi.org\/10.1371\/journal.pmed.1002105.","journal-title":"PLoS Med"},{"issue":"3","key":"760_CR44","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/ije\/dyw129","volume":"45","author":"C Gao","year":"2016","unstructured":"Gao C, Patel CJ, Michailidou K, Peters U, Gong J, Schildkraut J, et al. Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer. Int J Epidemiol. 2016;45(3):896\u2013908. https:\/\/doi.org\/10.1093\/ije\/dyw129.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"760_CR45","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","volume":"46","author":"S Cinti","year":"2005","unstructured":"Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005;46(11):2347\u201355. https:\/\/doi.org\/10.1194\/jlr.M500294-JLR200.","journal-title":"J Lipid Res"},{"issue":"12","key":"760_CR46","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI19246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796\u2013808. https:\/\/doi.org\/10.1172\/JCI19246.","journal-title":"J Clin Invest"},{"issue":"5091","key":"760_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87\u201391. https:\/\/doi.org\/10.1126\/science.7678183.","journal-title":"Science"},{"issue":"5","key":"760_CR48","doi-asserted-by":"publisher","first-page":"E745","DOI":"10.1152\/ajpendo.2001.280.5.E745","volume":"280","author":"PA Kern","year":"2001","unstructured":"Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001;280(5):E745\u201351. https:\/\/doi.org\/10.1152\/ajpendo.2001.280.5.E745.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"760_CR49","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1210\/endrev\/bnad015","volume":"44","author":"KA Brown","year":"2023","unstructured":"Brown KA, Scherer PE. Update on Adipose Tissue and Cancer. Endocr Rev. 2023;44(6):961\u201374. https:\/\/doi.org\/10.1210\/endrev\/bnad015.","journal-title":"Endocr Rev"},{"issue":"6","key":"760_CR50","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1084\/jem.20181616","volume":"216","author":"P Tiwari","year":"2019","unstructured":"Tiwari P, Blank A, Cui C, Schoenfelt KQ, Zhou GL, Xu YF, et al. Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer. J Exp Med. 2019;216(6):1345\u201358. https:\/\/doi.org\/10.1084\/jem.20181616.","journal-title":"J Exp Med"},{"issue":"27","key":"760_CR51","doi-asserted-by":"publisher","first-page":"41974","DOI":"10.18632\/oncotarget.9633","volume":"7","author":"SF Hendrayani","year":"2016","unstructured":"Hendrayani SF, Al-Harbi B, Al-Ansari MM, Silva G, Aboussekhra A. The inflammatory\/cancer-related IL-6\/STAT3\/NF-kappaB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts. Oncotarget. 2016;7(27):41974\u201385. https:\/\/doi.org\/10.18632\/oncotarget.9633.","journal-title":"Oncotarget"},{"issue":"3","key":"760_CR52","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10555-022-10031-9","volume":"41","author":"LE Hillers-Ziemer","year":"2022","unstructured":"Hillers-Ziemer LE, Kuziel G, Williams AE, Moore BN, Arendt LM. Breast cancer microenvironment and obesity: challenges for therapy. Cancer Metast Rev. 2022;41(3):627\u201347. https:\/\/doi.org\/10.1007\/s10555-022-10031-9.","journal-title":"Cancer Metast Rev"},{"issue":"49","key":"760_CR53","doi-asserted-by":"publisher","first-page":"35511","DOI":"10.1074\/jbc.M113.512640","volume":"288","author":"HH Al-Khalaf","year":"2013","unstructured":"Al-Khalaf HH, Mohideen P, Nallar SC, Kalvakolanu DV, Aboussekhra A. The cyclin-dependent kinase inhibitor p16INK4a physically interacts with transcription factor Sp1 and cyclin-dependent kinase 4 to transactivate microRNA-141 and microRNA-146b-5p spontaneously and in response to ultraviolet light-induced DNA damage. J Biol Chem. 2013;288(49):35511\u201325. https:\/\/doi.org\/10.1074\/jbc.M113.512640.","journal-title":"J Biol Chem"},{"key":"760_CR54","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3389\/fonc.2019.00596","volume":"9","author":"F S\u00e1nchez-Jim\u00e9nez","year":"2019","unstructured":"S\u00e1nchez-Jim\u00e9nez F, P\u00e9rez-P\u00e9rez A, de la Cruz-Merino L, S\u00e1nchez-Margalet V. Obesity and Breast Cancer: Role of Leptin. Front Oncol. 2019;9:596. https:\/\/doi.org\/10.3389\/fonc.2019.00596.","journal-title":"Front Oncol"},{"issue":"5","key":"760_CR55","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/cancers15051572","volume":"15","author":"GI Verras","year":"2023","unstructured":"Verras GI, Tchabashvili L, Chlorogiannis DD, Mulita F, Argentou MI. Updated Clinical Evidence on the Role of Adipokines and Breast Cancer: A Review. Cancers. 2023;15(5):1572. https:\/\/doi.org\/10.3390\/cancers15051572.","journal-title":"Cancers"},{"issue":"12","key":"760_CR56","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8(12):915\u201328. https:\/\/doi.org\/10.1038\/nrc2536.","journal-title":"Nat Rev Cancer"},{"issue":"7121","key":"760_CR57","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840\u20136. https:\/\/doi.org\/10.1038\/nature05482.","journal-title":"Nature"},{"issue":"4","key":"760_CR58","doi-asserted-by":"publisher","first-page":"bvag041","DOI":"10.1210\/jendso\/bvag041","volume":"10","author":"AJ Engel","year":"2026","unstructured":"Engel AJ, Samuel K, Bass IR, Lin SY, Antoniou IM, Yagnik R, et al. Insulin receptor expression and its association with hyperinsulinemia in triple negative breast cancer. J Endocr Soc. 2026;10(4):bvag041. https:\/\/doi.org\/10.1210\/jendso\/bvag041.","journal-title":"J Endocr Soc"},{"issue":"17","key":"760_CR59","doi-asserted-by":"publisher","first-page":"10233","DOI":"10.1111\/jcmm.15639","volume":"24","author":"F Gourgue","year":"2020","unstructured":"Gourgue F, Mignion L, Van Hul M, Dehaen N, Bastien E, Payen V, et al. Obesity and triple-negative-breast-cancer: Is apelin a new key target? J Cell Mol Med. 2020;24(17):10233\u201344. https:\/\/doi.org\/10.1111\/jcmm.15639.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"760_CR60","doi-asserted-by":"publisher","first-page":"e0118784","DOI":"10.1371\/journal.pone.0118784","volume":"10","author":"M Hale","year":"2015","unstructured":"Hale M, Itani F, Buchta CM, Wald G, Bing M, Norian LA. Obesity triggers enhanced MDSC accumulation in murine renal tumors via elevated local production of CCL2. PLoS ONE. 2015;10(3):e0118784. https:\/\/doi.org\/10.1371\/journal.pone.0118784.","journal-title":"PLoS ONE"},{"issue":"3","key":"760_CR61","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/JLB.4HI0517-210R","volume":"103","author":"VK Clements","year":"2018","unstructured":"Clements VK, Long T, Long R, Figley C, Smith DMC, Ostrand-Rosenberg S. Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells. J Leukoc Biol. 2018;103(3):395\u2013407. https:\/\/doi.org\/10.1002\/JLB.4HI0517-210R.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"760_CR62","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar V, Patel S, Tcyganov E, Gabrilovich DI. The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Trends Immunol. 2016;37(3):208\u201320. https:\/\/doi.org\/10.1016\/j.it.2016.01.004.","journal-title":"Trends Immunol"},{"issue":"2","key":"760_CR63","doi-asserted-by":"publisher","first-page":"ARTN79","DOI":"10.3892\/ijo.2024.5667","volume":"65","author":"C Jim\u00e9nez-Cortegana","year":"2024","unstructured":"Jim\u00e9nez-Cortegana C, Guti\u00e9rrez-Garc\u00eda C, S\u00e1nchez-Jim\u00e9nez F, Vilari\u00f1o-Garc\u00eda T, Flores-Campos R, P\u00e9rez-P\u00e9rez A, et al. Impact of obesity-associated myeloid-derived suppressor cells on cancer risk and progression (Review). Int J Oncol. 2024;65(2):ARTN79. https:\/\/doi.org\/10.3892\/ijo.2024.5667.","journal-title":"Int J Oncol"},{"issue":"37","key":"760_CR64","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1038\/s41388-025-03521-x","volume":"44","author":"ML Hawes","year":"2025","unstructured":"Hawes ML, Moody MA, Mccauley CR, Huddleston AG, Solanky M, Khosravi DH, et al. Oncogenic effects of ECM remodeling in obesity and breast cancer. Oncogene. 2025;44(37):3409\u201321. https:\/\/doi.org\/10.1038\/s41388-025-03521-x.","journal-title":"Oncogene"},{"key":"760_CR65","doi-asserted-by":"publisher","first-page":"1394719","DOI":"10.3389\/frmbi.2024.1394719","volume":"3","author":"M Gaber","year":"2024","unstructured":"Gaber M, Arnone AA, Vidi PA, Cook KL. The microbiome: a link between obesity and breast cancer risk. Front Microbiomes. 2024;3:1394719. https:\/\/doi.org\/10.3389\/frmbi.2024.1394719.","journal-title":"Front Microbiomes"},{"key":"760_CR66","doi-asserted-by":"publisher","first-page":"100155","DOI":"10.1016\/j.medmic.2025.100155","volume":"26","author":"HA Nazeer","year":"2025","unstructured":"Nazeer HA, Kannan S, Balakrishanan J, Nair VK, Kavitha Y. Bhosale. The gut microbiota and breast cancer: A comprehensive review of emerging links and therapeutic implications. Med Microecology. 2025;26:100155. https:\/\/doi.org\/10.1016\/j.medmic.2025.100155.","journal-title":"Med Microecology"},{"issue":"10","key":"760_CR67","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.3390\/nu13103656","volume":"13","author":"F Hossain","year":"2021","unstructured":"Hossain F, Majumder S, David J, Bunnell BA, Miele L. Obesity Modulates the Gut Microbiome in Triple-Negative Breast Cancer. Nutrients. 2021;13(10):3656. https:\/\/doi.org\/10.3390\/nu13103656.","journal-title":"Nutrients"},{"key":"760_CR68","doi-asserted-by":"publisher","unstructured":"Habanjar O, Bingula R, Decombat C, Diab-Assaf M, Caldefie-Chezet F, Delort L. Crosstalk of inflammatory cytokines within the breast tumor microenvironment. Int J Mol Sci. 2023;24(4). https:\/\/doi.org\/10.3390\/ijms24044002.","DOI":"10.3390\/ijms24044002"},{"issue":"10","key":"760_CR69","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.3390\/life15101634","volume":"15","author":"LX Chen","year":"2025","unstructured":"Chen LX, Shiao SL, Yuan Y. Translating Metabolic Interventions into Breast Cancer Therapy: A Comprehensive Review. Life-Basel. 2025;15(10):1634. https:\/\/doi.org\/10.3390\/life15101634.","journal-title":"Life-Basel"},{"issue":"1","key":"760_CR70","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1038\/s41467-023-39996-z","volume":"14","author":"HL Nguyen","year":"2023","unstructured":"Nguyen HL, Geukens T, Maetens M, Aparicio S, Bassez A, Borg A, et al. Obesity-associated changes in molecular biology of primary breast cancer. Nat Commun. 2023;14(1):4418. https:\/\/doi.org\/10.1038\/s41467-023-39996-z.","journal-title":"Nat Commun"},{"issue":"6","key":"760_CR71","doi-asserted-by":"publisher","first-page":"e70075","DOI":"10.1111\/obr.70075","volume":"27","author":"C Munteanu","year":"2026","unstructured":"Munteanu C, Dhanasekaran D. Obesity as a Systems-Level Driver of Cancer: Mechanisms and Nutritional Reprogramming. Obes Rev. 2026;27(6):e70075. https:\/\/doi.org\/10.1111\/obr.70075.","journal-title":"Obes Rev"},{"key":"760_CR72","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12885-015-1263-4","volume":"15","author":"ML Kwan","year":"2015","unstructured":"Kwan ML, Kroenke CH, Sweeney C, Bernard PS, Weltzien EK, Castillo A, et al. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015;15:278. https:\/\/doi.org\/10.1186\/s12885-015-1263-4.","journal-title":"BMC Cancer"},{"issue":"10","key":"760_CR73","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.3390\/ijerph19106093","volume":"19","author":"D Sat-Mu\u00f1oz","year":"2022","unstructured":"Sat-Mu\u00f1oz D, Mart\u00ednez-Herrera BE, Quiroga-Morales LA, Trujillo-Hern\u00e1ndez B, Gonz\u00e1lez-Rodr\u00edguez JA, Guti\u00e9rrez-Rodr\u00edguez LX, et al. Adipocytokines and Insulin Resistance: Their Role as Benign Breast Disease and Breast Cancer Risk Factors in a High-Prevalence Overweight-Obesity Group of Women over 40 Years Old. Int J Env Res Pub He. 2022;19(10):6093. https:\/\/doi.org\/10.3390\/ijerph19106093.","journal-title":"Int J Env Res Pub He"},{"issue":"2","key":"760_CR74","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s10549-012-2073-x","volume":"134","author":"S Niraula","year":"2012","unstructured":"Niraula S, Ocana A, Ennis M, Goodwin PJ. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis. Breast Cancer Res Tr. 2012;134(2):769\u201381. https:\/\/doi.org\/10.1007\/s10549-012-2073-x.","journal-title":"Breast Cancer Res Tr"},{"issue":"3","key":"760_CR75","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4048\/jbc.2020.23.e35","volume":"23","author":"SS Faria","year":"2020","unstructured":"Faria SS, Correa LH, Heyn GS, de Sant\u2019Ana LP, Almeida RDN, Magalhaes KG. Obesity and Breast Cancer: The Role of Crown-Like Structures in Breast Adipose Tissue in Tumor Progression, Prognosis, and Therapy. J Breast Cancer. 2020;23(3):233\u201345. https:\/\/doi.org\/10.4048\/jbc.2020.23.e35.","journal-title":"J Breast Cancer"},{"issue":"1","key":"760_CR76","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/cancers11010062","volume":"11","author":"S Ando","year":"2019","unstructured":"Ando S, Gelsomino L, Panza S, Giordano C, Bonofiglio D, Barone I, et al. Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms. Cancers (Basel). 2019;11(1):62. https:\/\/doi.org\/10.3390\/cancers11010062.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"760_CR77","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41523-021-00304-x","volume":"7","author":"MC Chang","year":"2021","unstructured":"Chang MC, Eslami Z, Ennis M, Goodwin PJ. Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis. NPJ Breast Cancer. 2021;7(1):97. https:\/\/doi.org\/10.1038\/s41523-021-00304-x.","journal-title":"NPJ Breast Cancer"},{"issue":"9","key":"760_CR78","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3390\/cancers13092222","volume":"13","author":"ML Maliniak","year":"2021","unstructured":"Maliniak ML, Miller-Kleinhenz J, Cronin-Fenton DP, Lash TL, Gogineni K, Janssen EAM, et al. Crown-Like Structures in Breast Adipose Tissue: Early Evidence and Current Issues in Breast Cancer. Cancers (Basel). 2021;13(9):2222. https:\/\/doi.org\/10.3390\/cancers13092222.","journal-title":"Cancers (Basel)"},{"key":"760_CR79","doi-asserted-by":"publisher","unstructured":"Xie M, Sfakianakis E, Tan P. Complex interaction of adipokines in breast cancer and anti-tumour immunity: A new paradigm for cancer treatment. J Cancer Res Cell Ther. 2021;5(2). https:\/\/doi.org\/10.31579\/2640-1053\/077.","DOI":"10.31579\/2640-1053\/077"},{"issue":"1","key":"760_CR80","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","volume":"104","author":"N Mavaddat","year":"2019","unstructured":"Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet. 2019;104(1):21\u201334. https:\/\/doi.org\/10.1016\/j.ajhg.2018.11.002.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"760_CR81","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/jnci\/djy040","volume":"110","author":"RE Patterson","year":"2018","unstructured":"Patterson RE, Marinac CR, Sears DD, Kerr J, Hartman SJ, Cadmus-Bertram L, et al. The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes. J Natl Cancer Inst. 2018;110(11):1239\u201347. https:\/\/doi.org\/10.1093\/jnci\/djy040.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"760_CR82","doi-asserted-by":"publisher","first-page":"16897","DOI":"10.1038\/s41598-025-01705-9","volume":"15","author":"PP Stromland","year":"2025","unstructured":"Stromland PP, Bertelsen BE, Viste K, Chatziioannou AC, Bellerba F, Robinot N, et al. Effects of metformin on transcriptomic and metabolomic profiles in breast cancer survivors enrolled in the randomized placebo-controlled MetBreCS trial. Sci Rep. 2025;15(1):16897. https:\/\/doi.org\/10.1038\/s41598-025-01705-9.","journal-title":"Sci Rep"},{"issue":"5","key":"760_CR83","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/pharmaceutics17050558","volume":"17","author":"Z Sirhan","year":"2025","unstructured":"Sirhan Z, Abu Nada A, Anabtawi N, Thyagarajan A, Sahu RP. Metformin-Based Combination Approaches for Triple-Negative Breast Cancer. Pharmaceutics. 2025;17(5):558. https:\/\/doi.org\/10.3390\/pharmaceutics17050558.","journal-title":"Pharmaceutics"},{"issue":"20","key":"760_CR84","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1001\/jama.2022.6147","volume":"327","author":"PJ Goodwin","year":"2022","unstructured":"Goodwin PJ, Chen BE, Gelmon KA, Whelan TJ, Ennis M, Lemieux J, et al. Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial. JAMA. 2022;327(20):1963\u201373. https:\/\/doi.org\/10.1001\/jama.2022.6147.","journal-title":"JAMA"},{"issue":"3","key":"760_CR85","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2206038.","journal-title":"N Engl J Med"},{"issue":"10402","key":"760_CR86","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(23)01200-X","volume":"402","author":"WT Garvey","year":"2023","unstructured":"Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2023;402(10402):613\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(23)01200-X.","journal-title":"Lancet"},{"key":"760_CR87","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejim.2024.07.037","volume":"130","author":"LE Simental-Mend\u00eda","year":"2024","unstructured":"Simental-Mend\u00eda LE, Simental-Mend\u00eda M, Barrag\u00e1n-Z\u00fa\u00f1iga J, Navarro-Tinoco L. Effect of tirzepatide on leptin and adiponectin levels. Eur J Intern Med. 2024;130:168\u201370. https:\/\/doi.org\/10.1016\/j.ejim.2024.07.037.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"760_CR88","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1210\/clinem\/dgaa863","volume":"106","author":"MK Thomas","year":"2021","unstructured":"Thomas MK, Nikooienejad A, Bray R, Cui XW, Wilson J, Duffin K, et al. Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes. J Clin Endocr Metab. 2021;106(2):388\u201396. https:\/\/doi.org\/10.1210\/clinem\/dgaa863.","journal-title":"J Clin Endocr Metab"},{"issue":"17","key":"760_CR89","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.3390\/cancers14174139","volume":"14","author":"E Papakonstantinou","year":"2022","unstructured":"Papakonstantinou E, Piperigkou Z, Karamanos NK, Zolota V. Altered Adipokine Expression in Tumor Microenvironment Promotes Development of Triple Negative Breast Cancer. Cancers (Basel). 2022;14(17):4139. https:\/\/doi.org\/10.3390\/cancers14174139.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"760_CR90","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41523-025-00755-6","volume":"11","author":"RJ Chehayeb","year":"2025","unstructured":"Chehayeb RJ, Odzer N, Albany RA, Ferrucci L, Sarpong D, Perez-Escamilla R, et al. Breastfeeding attributable fraction of triple negative breast cancer in the US. NPJ Breast Cancer. 2025;11(1):40. https:\/\/doi.org\/10.1038\/s41523-025-00755-6.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"760_CR91","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1186\/s12967-025-06970-w","volume":"23","author":"R Salemi","year":"2025","unstructured":"Salemi R, Sergi V, Basile MS, Bravaccini S, Frittitta L, Graziano ACE, et al. Microenvironmental determinants of cancer progression during obesity: emerging evidence and novel perspectives. J Transl Med. 2025;23(1):995. https:\/\/doi.org\/10.1186\/s12967-025-06970-w.","journal-title":"J Transl Med"}],"container-title":["Current Obesity Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-026-00760-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13679-026-00760-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-026-00760-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:32:57Z","timestamp":1789108377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13679-026-00760-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["760"],"URL":"https:\/\/doi.org\/10.1007\/s13679-026-00760-1","relation":{},"ISSN":["2162-4968"],"issn-type":[{"value":"2162-4968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"2 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"80"}}